Blood Processing: Component Separation, Storage, and Clinical Applications

Blood processing transforms whole blood donations into specialized components, enabling targeted therapy and efficient resource utilization. One donation can help multiple patients.

Collection & Initial Processing

  1. Phlebotomy: 450–500 mL whole blood + anticoagulant (CPD, CP2D, CPDA-1) into primary bag with satellite bags
  2. Filtration: Leukoreduction (prestorage) — removes >99.9% WBCs → ↓febrile reactions, HLA alloimmunization, CMV transmission, immunomodulation
  3. Centrifugation ("hard spin"): Separates red cells (bottom) from platelet-rich plasma (top)
  4. Second spin ("soft spin"): PRP → platelet concentrate (bottom) + plasma (top)

Major Components & Specifications

Specialized Products

  • Washed RBCs: Removes plasma proteins (IgA deficiency, severe allergic reactions)
  • Irradiated components: 25 Gy — prevents TA-GVHD (transfusion-associated GVHD) for immunocompromised
  • CMV-safe: Leukoreduced + seronegative donor
  • Pathogen-reduced: Amustaline/UVA (platelets/plasma) — broad pathogen inactivation
  • Pediatric aliquots: Small-volume splits

Quality & Safety

  • Testing (per donation): HIV, HBV, HCV, HTLV, syphilis, WNV, Zika, Chagas (risk-based) — NAT + serology
  • Bacterial culture: Platelets (day 1–2)
  • ABO/Rh typing, antibody screen
  • Traceability: ISBT 128 barcodes — vein-to-vein

Clinical Impact

  • Component therapy avoids volume overload, transmits only needed elements
  • Inventory management: RBCs (weeks), platelets (days) — constant demand
  • Patient blood management (PBM): Optimize Hb, minimize bleeding, harness physiology → reduce transfusion

Blood Disorders - Related Articles

Health Sciences © https://www.222health.com

ComponentVolumeStorageShelf LifeKey Indications
Red Blood Cells (RBC)~250–350 mL (Hct 55–65%)1–6°C42 days (CPDA-1)Anemia, hemorrhage, exchange transfusion
Fresh Frozen Plasma (FFP)~200–250 mL≤-18°C12 months (≤-18°C)Coagulopathy, massive transfusion, TTP
Platelets (apheresis or pooled 4–6)~200–300 mL20–24°C, agitation5–7 daysThrombocytopenia, platelet dysfunction
Cryoprecipitate~15–20 mL (from 1 FFP)≤-18°C12 monthsFibrinogen deficiency, vWD, DIC
Cryo-poor plasmaRemaining plasma≤-18°C12 monthsVolume, other factors